
Novasign is an innovative company specializing in bioprocess development and automated process control for diverse industries including pharma, enzyme manufacturing, and cultured food. They leverage advanced machine learning tools and a unique workflow combining smart experimental design with hybrid modeling to significantly reduce bioprocess development timelines, potentially by up to 70%. Their solutions, such as Novasign Studio, Hybrid Modeling Toolbox, and Digital Twin, aim to improve process understanding, enable efficient data alignment, and facilitate real-time process visualization and control. Founded in August 2019 as a spin-off from BOKU university, Novasign has assisted over 25 clients, demonstrating a commitment to open ecosystems and seamless integration with third-party solutions to provide powerful and controlled collaborative environments.

Novasign is an innovative company specializing in bioprocess development and automated process control for diverse industries including pharma, enzyme manufacturing, and cultured food. They leverage advanced machine learning tools and a unique workflow combining smart experimental design with hybrid modeling to significantly reduce bioprocess development timelines, potentially by up to 70%. Their solutions, such as Novasign Studio, Hybrid Modeling Toolbox, and Digital Twin, aim to improve process understanding, enable efficient data alignment, and facilitate real-time process visualization and control. Founded in August 2019 as a spin-off from BOKU university, Novasign has assisted over 25 clients, demonstrating a commitment to open ecosystems and seamless integration with third-party solutions to provide powerful and controlled collaborative environments.